Why the study?
Does low molecular weight heparin fragment reduce the incidence of deep venous thrombosis in patients undergoing major elective general surgery?
Does low molecular weight heparin fragment reduce the incidence of deep venous thrombosis in patients undergoing major elective general surgery?
Once daily subcutaneous injection of 2,500 anti Xa units of low molecular weight heparin fragment effectively and safely reduces deep venous thrombosis in patients undergoing major elective general surgery.
No takes yet. Share an insight, caveat, or question.
Supports LMWH prophylaxis in major elective general surgery; confirms DVT reduction versus placebo in RCT.
Ockelford et al. (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: